Oramed Pharmaceuticals Inc. (ORMP) — Dilution Risk Analysis

Current Snapshot

Oramed Pharmaceuticals Inc. (ORMP) has a DilutionWatch score of 21/10 and is classified as LOW risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
41,597,354 Source
Public Float
28,572,953 Source
Float as % of Outstanding
68.7%

Dilution Risk Score

Score: 21/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: 4 8, 8-K 2.

FormFiledAccession
4 2026-03-31 0001213900-26-037446
4 2026-03-31 0001213900-26-037447
8-K 2026-03-31 0001213900-26-037474
4 2026-03-18 0001213900-26-031011
4 2026-03-18 0001213900-26-031012
4 2026-03-18 0001213900-26-031013
4 2026-03-18 0001213900-26-031015
4 2026-03-16 0001213900-26-028291
8-K 2026-02-20 0001012975-26-000195
4 2026-01-29 0001213900-26-009479

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 64 months Source
Three-year share count growth 3.12% Source

DilutionWatch Analysis

Risk Level
LOW (Score: 21/10) Source
Cash Runway
64 months Source
Share Count Growth (3-Year)
3.12% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.